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Supplementary Figure S1: Validation of Amot over-expressing construct 
One 2-cell blastomere was injected with either 1.0µg/µl Ruby mRNA as a control or 0.8µg/µl 
Amot mRNA with 0.2µg/µl Ruby mRNA and cultured for 24 hours (N=9). Protein expression 
was confirmed with immunofluorescence. Scale bars: 10µm. 
 
 
 
 
 
 
 
 
 Supplementary Figure S2: Amot is down-regulated in outside cells after 48 hours of Amot 
over-expression 
One blastomere of the 2-cell stage embryo was injected with 0.8µg/µl of p130 Amot mRNA 
and 0.2µg/µl Ruby mRNA to mark the injected clones. Red outlines mark the Ruby-positive 
cells, white outline mark the inside cells, white arrows point to nuclear Yap accumulation in 
outside cells of the over-expressing clones. Over 48 hours Amot over-expression became 
restricted to the inside cells, whereas in the outside cells Amot became dramatically down-
regulated (N=16). Scale bars: 10µm.  
 
 
 
 
  
Supplementary Figure S3: qRT-PCR of Amot-RNAi embryos with a dsRNA targeting the 
3’UTR of Amot 
Injection of a dsRNA targeting the 3’UTR of Amot into zygotes depleted Amot transcripts by 
79.4±1% when assessed at the blastocyst stage (N=20). Error bars represent standard error 
of the mean. Student’s t-test was used to test significance. 
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Supplementary Figure S4: Amot over-expression demonstrates Amot/Yap co-localisation. 
One 8-cell blastomere was injected with 0.8µg/µl p130 Amot mRNA and cultured for 12 
hours (N=13). The altered localisation of Yap suggests it co-localises with Amot, indicating a 
direct interaction between Amot and Yap in the embryo. This direct interaction represents a 
Hippo pathway-independent mechanism, as Yap is directly sequestered from the nucleus by 
Amot. Scale bars: 10µm. 
 
 
 
 
 
 
 
  
 
Supplementary Figure S5. qRT-PCR of Lats1;  Lats2-RNAi embryos 
Injection of a combination of 3 siRNAs against Lats1 and 3 siRNAs against Lats2 into zygotes 
depleted Lats1 transcripts by 41±9% and Lats2 transcripts by 50±6% when assessed at the 
blastocyst stage (N=18). Error bars represent standard error of the mean. Student’s t-test 
was used to test significance. 
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Supplementary Figure S6: qRT-PCR of Yap-RNAi embryos 
Injection of a mixture of three different siRNAs targeted against Yap into zygotes was able to 
deplete Yap transcripts by 76±4% after 2 days (N=20). However, Cdx2 transcripts was not 
significantly reduced (N=20). This is most likely due to functional redundancies between Yap 
and its homologue Taz. Error bars represent standard error of the mean. Student’s t-test 
was used to test significance. 
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Supplementary Table S1: Experimental design of the embryo transfer experiment 
Genotype Injection Embryos transferred Surrogates 
GFP  Control siRNA 20 (Group 1) 2 
WT  Control siRNA 20 (Group 1) 
GFP Control siRNA 20 (Group 2) 2 
WT Amot siRNA 20 (Group 2) 
GFP Control siRNA 20 (Group 3) 2 
WT Amot; Amotl1; 
Amotl2 siRNA 
20 (Group 3) 
 
3 groups of embryos were transferred into pseudo-pregnant surrogates. Each group consists 
of 20 GFP and 20 WT embryos. GFP embryos are always injected with control siRNA. 10 GFP 
embryos and 10 WT embryos were transferred into one uterine horn of 1 surrogate. In total 
2 surrogates were used for each group. 
 
 
 
 
 
 
 
 
 
 
Supplementary Table S2: Outcome of the embryo transfer experiment 
Outcome Embryos 
transferred 
Embryos 
recovered 
GFP+ 
embryos 
GFP- 
embryos 
Normalized 
for 
background 
and transfer 
efficiency 
Group 1: 
Control 
40 38 20 (100%) 18 (90%) 100% 
Group 2: 
Amot-RNAi 
40 22 17 (85%) 5 (25%) 32.7% 
Group 3: 
Amot; 
Amotl1; 
Amotl2-RNAi 
40 20 16 (80%) 4 (20%) 27.8% 
 
The outcome of the embryo transfers. To assess for developmental success the embryos 
were recovered at E7.5. For the group 1 (control), out of the 40 embryos transferred, 38 
embryos were recovered, of those 20 (100%) were GFP+ and 18 (90%) were GFP-. For Amot-
RNAi, out of 40 embryos transferred, 22 embryos were recovered, of those 17 (85%) were 
GFP+ and 5 (25%) were GFP-. For the Amot; Amotl1; Amotl2-RNAi, out of 40 embryos 
transferred, 20 embryos were recovered, of those 16 (80%) were GFP+ and 4 (20%) were 
GFP-. After normalizing for the transfer efficiency of the different recipients and background 
of the embryos, 100% of the control RNAi embryos progressed successfully to E7.5, 
compared to 32.7% of Amot-RNAi embryos (p<0.05, χ2 test, compared to control) and 27.8% 
of Amot; Amotl1; Amotl2-RNAi embryos (p<0.05, χ2 test, compared to control). There was 
no significant difference between the developmental success of Amot-RNAi and Amot; 
Amotl1; Amotl2-RNAi embryos (p=0.67, χ2 test).  
